Literature DB >> 20398968

[Detection of contralateral axillary sentinel lymph node by lymphoscintigraphy in breast cancer: prognostic implications].

B Luján1, D Carrera, J Picas, V Izquierdo, R Siurana, L Quintero, C Martínez de Vírgala.   

Abstract

The role of nuclear medicine in the detection of sentinel lymph nodes (SLNs) in primary breast cancer is very useful to determine regional lymphatic drainage from the affected breast, mainly its anatomical and/or tumoral individual variability and to determine the initial tumor stage. We present the case of an infiltrating ductal carcinoma of the breast (T2) in the junction of the inner quadrants of the right breast studied by lymphoscintigraphy and gamma probe detection. Three non-metastatic sentinel lymph nodes were found with the selective lymphadenectomy: two in the ipsilateral axilla and one in the contralateral axilla. The lymphoscintigraphic finding of the axillary sentinel lymph node contralateral to the affected breast demonstrates the individual anatomical variability in mammary drainage. It emphasizes the importance of nuclear medicine imaging techniques in its detection and generates new prognostic approaches with impact on therapeutic measures and patient follow-up. 2009 Elsevier España, S.L. y SEMNIM. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20398968     DOI: 10.1016/j.remn.2009.12.007

Source DB:  PubMed          Journal:  Rev Esp Med Nucl        ISSN: 0212-6982


  2 in total

1.  Sentinel Lymph Node Detection in Contralateral Axilla at Initial Presentation of a Breast Cancer Patient: Case Report.

Authors:  Gülin Uçmak Vural; Ilgın Şahiner; Semra Demirtaş; Hülya Efetürk; Bedriye Büşra Demirel
Journal:  Mol Imaging Radionucl Ther       Date:  2015-06-05

2.  Bilateral axillary and internal mammary drainage in breast cancer without prior surgery during sentinel node mapping.

Authors:  Justo Serrano Vicente; M Luz Domínguez Grande; Carmen Durán Barquero; Jrafael Infante Torre; Lucía García Bernardo; J Ignacio Rayo Madrid; M Isabel Correa Antúnez
Journal:  Indian J Nucl Med       Date:  2011-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.